CA-BERKELEY-SKYDECK
2.8.2022 13:02:06 CEST | Business Wire | Press release
Berkeley SkyDeck , the global hub for entrepreneurship and leading accelerator, today announced that applications are now open for its 15th cohort class, with a final deadline of August 31, 2022. Applications are available here . Batch 15 cohorts can take advantage of new tracks added in the last year, including the Aero-Astro Track, led by advisor Robin Riedel of McKinsey and Company, and the Blockchain/Crypto Track, led by advisor Linda Kreitzman. Berkeley SkyDeck’s Chip Track also named a new advisor, David Horsley of UC Davis. In addition, Berkeley SkyDeck will launch a CivTech Track in the coming year, in partnership with the Center for Security in Politics at UC Berkeley, with former Secretary of Homeland Security Janet Napolitano leading the track as a primary advisor. In addition to these new tracks, SkyDeck will continue to work with startups in industries that have always been an area of focus for venture investors, including consumer, enterprise software, biotech, greentech and more.
Berkeley SkyDeck accepts just over 1.5% of startups that apply and approximately 20 to 25 startups overall for each of its cohorts. Cohort companies receive $200,000 in funding, $750,000 worth of free and discounted resources, and access to SkyDeck’s unsurpassed network of UC Berkeley alumni, faculty, and advisors. Alumni of Berkeley SkyDeck have enjoyed great success in their respective industries, collectively raising more than $1.7 billion in funding. The recently launched Berkeley SkyDeck Europe is currently working with its first group of cohorts, who will present their own Demo Day on October 20, 2022.
“Our mission at Berkeley SkyDeck is to continue the tradition of excellence in entrepreneurship and innovation that makes UC Berkeley one of the top public universities in the world. Expanding our operations in Europe and opening additional tracks for our cohorts are just a couple examples of how we are striving to meet the needs of founders around the world,” said Caroline Winnett, Executive Director. “I am looking forward to seeing what these batch applicants have to offer – and how we can leverage the university’s vast resources to set them up for success.”
Berkeley SkyDeck’s newest tracks reflect trends in growth and investments. Last year, for example, aerospace startups raised $15.4 billion while US semiconductor and chip investment reached $2.6 billion in 2021 , nearly doubling in just three years. Civtech is also burgeoning, with the industry’s transaction volume rising to $14 billion total in 2021 .
“While Berkeley SkyDeck might be rooted here in Silicon Valley, our reach is global, and we’re excited to see how both homegrown and international startups tackle the issues in their industries across all of our tracks,” said Chon Tang, Founding Partner, Berkeley SkyDeck Fund. “As we evaluate, advise, and potentially invest, we are continually energized by these fresh ideas and new approaches. The SkyDeck Fund is ready and waiting to take these newest cohort companies to the next level.”
In March 2022, Berkeley SkyDeck recently announced the close of the $60 million SkyDeck Fund II, which continues to actively fund companies. The SkyDeck Fund has invested in 160 companies to date, representing a wide range of businesses and industries, from 30 countries around the world. Unlike other VC funds, the SkyDeck Fund shares half of its profits with UC Berkeley, helping to continue the university’s mission of delivering excellence in education.
Berkeley SkyDeck will conduct extensive research on applicants, and will hold interviews between September and October 2022. The six-month program will begin in November 2022, concluding at the end of April 2023. Berkeley SkyDeck will host the cohort’s Demo Day for investors on April 4, 2023.
About Berkeley SkyDeck
Berkeley SkyDeck is a leading accelerator and the global hub for entrepreneurship. As UC Berkeley’s largest and most prominent accelerator, SkyDeck combines hands-on mentorship with the vast resources of its research university. SkyDeck is the only accelerator of its kind that offers the value of a dedicated investment fund alongside the resources and network of a top university. To date, SkyDeck startups have raised more than $1.7 billion in aggregate. Participating startups have access to SkyDeck’s 420 advisors, 70 industry partners, and a network of more than 510,000 UC Berkeley alumni. For more information, see skydeck.berkeley.edu .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005245/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release
The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release
Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom